Welcome to our dedicated page for Gallagher (ARTHUR J.) & Co. SEC filings (Ticker: AJG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Arthur J. Gallagher & Co. filings document the reporting record of a global insurance brokerage, risk management and consulting services company with common stock listed on the New York Stock Exchange under AJG. Its 8-K filings regularly report operating results and financial condition, including earnings releases, GAAP and non-GAAP measures, supplemental quarterly data and CFO commentary furnished through Regulation FD disclosures.
The company’s SEC filings also cover proxy governance, executive compensation, director elections, board composition and shareholder meeting matters. Material-event reports document investor presentations, board changes, securities registration information and completed acquisition accounting, including acquired-company financial statements and pro forma financial information for the AssuredPartners transaction.
Caplan Deborah H reported acquisition or exercise transactions in this Form 4 filing.
Director Deborah H. Caplan received a grant of 1,110 shares of Arthur J. Gallagher & Co. common stock in the form of a restricted stock unit award. The units vest on the earlier of one year after the grant date or her departure from the Board. Following this award, she directly holds 2,650 shares of common stock.
Arthur J. Gallagher & Co. director Teresa Hillary Clarke reported an acquisition of 1,110 shares of common stock as a grant or award, at a stated price of $0.00 per share. This award is structured as restricted stock units that vest on the earlier of one year after the grant date or her departure from the Board.
Following this compensation-related award, Clarke directly holds a total of 5,566.726 shares of Arthur J. Gallagher & Co. common stock. The transaction reflects routine equity compensation for board service rather than an open-market purchase or sale.
Coldman David John reported acquisition or exercise transactions in this Form 4 filing.
Arthur J. Gallagher & Co. director David John Coldman received a grant of 1,110 shares of Common Stock in the form of a restricted stock unit award. The award vests on the earlier of one year after the grant date or his departure from the Board. Following this grant, he holds 16,344 shares directly.
Harries Richard de Winton Wilkin reported acquisition or exercise transactions in this Form 4 filing.
Arthur J. Gallagher & Co. director Harries Richard de Winton Wilkin reported receiving a grant of 1,110 shares of common stock as a restricted stock unit award. The award vests on the earlier of one year after the grant date or his departure from the Board. Following this grant, he beneficially owns 2,413 shares of common stock directly.
JOHNSON DAVID S reported acquisition or exercise transactions in this Form 4 filing.
Arthur J. Gallagher & Co. director David S. Johnson received a grant of 1,110 shares of Common Stock as a restricted stock unit award. The award carries a price of $0.00 per share and is compensation-related rather than a market purchase.
According to the footnote, the restricted stock units vest on the earlier of one year after the grant date or Johnson’s departure from the Board. After this award, Johnson directly holds a total of 47,150.018 shares of Arthur J. Gallagher & Co. common stock, showing this grant is a relatively small addition to his existing position.
Miskel Christopher C. reported acquisition or exercise transactions in this Form 4 filing.
Arthur J. Gallagher & Co. director Christopher C. Miskel reported an equity compensation grant of 1,110 shares of Common Stock. This award is described as a restricted stock unit grant that vests on the earlier of one year after the grant date or his departure from the Board. Following this grant, he directly holds 10,447.692 shares of the company’s common stock.
NICOLETTI RALPH J reported acquisition or exercise transactions in this Form 4 filing.
Arthur J. Gallagher & Co. director Ralph J. Nicoletti received a grant of 1,110 shares of common stock as a restricted stock unit award. The award vests on the earlier of one year after the grant date or his departure from the Board. Following this grant, he holds 18,414.305 shares directly.
ROSENTHAL NORMAN L reported acquisition or exercise transactions in this Form 4 filing.
Arthur J. Gallagher & Co. director Norman L. Rosenthal received an equity award of 1,110 shares of Common Stock as a grant. The Form 4 shows this as a restricted stock unit award with no cash price per share. After this award, Rosenthal directly holds 43,326.66 shares of Arthur J. Gallagher & Co. common stock. The restricted stock units vest on the earlier of one year after the grant date or his departure from the Board, making this a routine, compensation-related equity grant rather than an open-market purchase.
Arthur J. Gallagher & Co. reported the results of its Annual Meeting of Stockholders held on May 12, 2026. Stockholders elected all nine director nominees to serve until the 2027 annual meeting, with each nominee receiving strong majority support in votes cast.
Stockholders also approved the ratification of Ernst & Young LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. In addition, they approved, on a non-binding advisory basis, the company’s named executive officers’ compensation, commonly referred to as Say‑on‑Pay.
Arthur J. Gallagher & Co. reported strong first-quarter 2026 results, with total revenues rising to $4.76 billion from $3.73 billion and net earnings increasing to $823 million from $709 million. Diluted earnings per share grew to $3.16 from $2.72.
Brokerage revenues reached $4.29 billion, while risk management revenues before reimbursements were $428 million, both up double digits. Operating cash flow was a solid $957 million. The company spent $289 million on acquisitions and ended March 31, 2026 with $12.87 billion in net corporate and other debt and $23.80 billion in total stockholders’ equity.